CWM
RCKT icon

CIBC World Markets’s Rocket Pharmaceuticals RCKT Stock Holding History

CIBC World Markets’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$25.3K Sell
10,334
-6,768
-40% -$34.3K ﹤0.01% 1518
2025
Q1 		$114K Buy
+17,102
New +$169K ﹤0.01% 1578

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

CIBC World Markets's RCKT Position: Q2 2025 in Review

CIBC World Markets reduced its Rocket Pharmaceuticals (RCKT) stake by 40% in Q2 2025, selling an estimated $34.3K and leaving 10,334 shares worth $25.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1518.

CIBC World Markets first reported a position in RCKT in Q1 2025 and has held it in 2 quarters since. The position peaked at $114K in Q1 2025. 196 funds tracked by Wall St. Rank hold RCKT as of Q2 2025.

  • CIBC World Markets held 10,334 shares of Rocket Pharmaceuticals worth $25.3K as of Q2 2025.
  • CIBC World Markets sold 6,768 Rocket Pharmaceuticals shares in Q2 2025, an estimated $34.3K.
  • Rocket Pharmaceuticals made up ﹤0.01% of CIBC World Markets's portfolio in Q2 2025, its #1518 holding.
  • CIBC World Markets first reported a position in Rocket Pharmaceuticals in Q1 2025 and has held it in 2 quarters since.
  • CIBC World Markets's Rocket Pharmaceuticals position peaked at $114K in Q1 2025.
  • 196 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2025.

Based on CIBC World Markets's 13F filing for Q2 2025, filed 14 Aug 2025.